Identification and differential regional expression of KOR-3/ORL-1 gene splice variants in mouse brain

Cotzias Laboratory of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
FEBS Letters (Impact Factor: 3.34). 10/1998; 435(1):65-8. DOI: 10.1016/S0014-5793(98)01039-4
Source: PubMed

ABSTRACT KOR-3, also known as ORL-1, is a member of the opioid receptor family, encoding the murine receptor for orphanin FQ/nociceptin. In the current studies we have identified five different splice variants of KOR-3 in mouse brain, three of which have not been previously reported. In addition to variants with a 15 bp deletion at the 3'-end of the first coding exon (KOR-3d) and an 81 bp insertion between the second and third coding exons (KOR-3e), three new variants with insertions of 34 (KOR-3a), 98 (KOR-3b), and 139 bp (KOR-3c) between the first and second coding exons have been obtained. The expression of the three variants in mouse brain varies markedly among brain regions with a distribution which is quite distinct from KOR-3 itself. Of greatest interest was the presence of high levels of KOR-3a in the striatum, a region with no demonstrable KOR-3, and in the cortex. KOR-3c was seen in the periaqueductal gray and hypothalamus, regions where KOR-3 predominated. The brainstem had similar levels of KOR-3, KOR-3a, and KOR-3d. In contrast, KOR-3d was most prominent in the cerebellum. KOR-3b levels were very low throughout.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Mediterranean ecosystems, natural wildfires and prescribed burning play an important role. In order to obtain a better understanding of the impact of charcoal on the nitrogen (N) cycling in soil, 15N-enriched pyrogenic organic material (PyOM) obtained from “Lolium perenne” charred for 4min at 350°C was mixed with a typical Mediterranean agricultural soil and incubated for 72 days under controlled conditions. The main objectives were to analyze the availability of N from this material and to obtain more insight into the recalcitrance of PyOM in soils. Addition of artificially produced 15N-PyOM increased the biomass production and N retention. After 72 days of incubation time, 10% of the 15N added to the soil (15Nadd) was incorporated into new grass biomass. Solid-state 15N NMR spectroscopy revealed that at least some of this N derived from the degradation of pyrrole-type structures. Increase of the amide-N intensity in the solid-state 15N NMR spectrum of the incubated soils indicated further that some 15N from the PyOM was also incorporated into new microbial biomass. Our results confirmed a relatively low recalcitrance of N-rich PyOM. Since during its degradation, N is only slowly transferred into a plant-available form, it may contribute to the observed improvement of soil fertility by avoiding fast N losses due to leaching and volatilization as a slow N-release fertilizer.
    Soil Biology and Biochemistry 12/2011; 43(12):2368-2373. DOI:10.1016/j.soilbio.2011.08.008 · 4.41 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite high sequence similarity between NOP (nociceptin/orphaninFQ opioid peptide) and opioid receptors, marked differences in endogenous ligand selectivity, signal transduction, phosphorylation, desensitization, internalization and trafficking have been identified; underscoring the evolutionary difference between NOP and opioid receptors. Activation of NOP receptors affects nociceptive transmission in a site-specific manner, with antinociceptive effects prevailing after peripheral and spinal activation, and pronociceptive effects after supraspinal activation in rodents. The net effect of systemically administered NOP receptor agonists on nociception is proposed to depend on the relative contribution of peripheral, spinal and supraspinal activation and this may depend on experimental conditions. Functional expression and regulation of NOP receptors at peripheral and central sites of the nociceptive pathway exhibits a high degree of plasticity under conditions of neuropathic and inflammatory pain. In rodents, systemically administered NOP receptor agonists exerted antihypersensitive effects in models of neuropathic and inflammatory pain. However they were largely ineffective in acute pain while concomitantly evoking severe motor side effects. In contrast, systemic administration of NOP receptor agonists to non-human primates (NHPs) exerted potent and efficacious antinociception in the absence of motor and sedative side effects. The reason for this species difference with respect to antinociceptive efficacy and tolerability is not clear. Moreover, co-activation of NOP and μ-opioid peptide (MOP) receptors synergistically produced antinociception in NHPs. Hence, both selective NOP receptor as well as NOP/MOP receptor agonists may hold potential for clinical use as analgesics effective in conditions of acute and chronic pain.
    British Journal of Pharmacology 08/2014; 171(16):3777-3800. DOI:10.1111/bph.12744 · 4.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report the genomic structure and functional activities of the promoter regions of the human opioid-receptor-like gene ORL1 and its 5′-adjacent gene GAIP (G alpha interacting protein). The transcription and alternative splicing of human ORL1 are controlled by two alternate promoters, located approximately 10 kb apart. The two promoter regions lack a TATA-box and are GC rich. Promoter 1A initiates, from a single transcription start point (TSP), two transcripts: one consisting of exons 1A, 1B, 2, etc., the other without exon 1B. A potential ATG codon upstream of the initiation codon of ORL1 starts a new open-reading frame encoding a theoretical polypeptide of 205 amino acid residues. The promoter 1B transcribes, from multiple TSPs, only one mRNA starting with exon 1B. Two different repeat sequence polymorphisms are found in the ORL1 promoter regions. Luciferase reporter gene assays with promoter regions and a series of deletion mutants have mapped the core-promoter 1A and 1B within two short fragments. DNA sequencing and a database search reveal that the human GAIP gene is located upstream of ORL1 and is oriented in the opposite direction. The transcription and alternative splicing of GAIP are also under the control of alternate promoters. The first exons of ORL1 and GAIP are separated by only 83 bp. This 83 bp fragment, together with short surrounding sequences from both first exons, functions bi-directionally as a core-promoter for both genes. The transcription and alternative splicing of human ORL1 and GAIP are cell-type specific. While GAIP is expressed in both NT2 precursor cells and differentiated NT2 neuronal cells, ORL1 is only expressed in differentiated NT2 neurons. Since ORL1 is a G protein-coupled receptor and GAIP interacts with G protein α subunits, their physical linkage in the genome and co-operative transcriptional regulation may play a significant role in ORL1 receptor signal transduction.
    Journal of Molecular Biology 12/2000; 304(3):259-270. DOI:10.1006/jmbi.2000.4212 · 3.96 Impact Factor

Full-text (2 Sources)

Available from
May 15, 2014